Haleos Labs

SMS Lifesciences India Limited is a pharmaceutical company engaged in the business of manufacturing Active Pharma Ingredients (APIs) and their crucial chemical intermediates. Its long-term ambition is to achieve the reputation of being one of the best Bulk Drug and API Intermediates manufacturers with comprehensive excellence and presence in regulated markets. The company consistently considers Research and Development (R&D) as a critical component for its sustained growth, stepping up investments to adapt to the changing market scenario. It operates manufacturing units in Kazipally and Jeedimetla with a combined installed capacity of 65 KL for producing APIs and their intermediates. As part of its strategy, the company's short-term goal is to increase its market share in existing regions and establish a strong foundation for growth in the United States and Europe. Demonstrating strong financial performance, the company's Gross Profit before interest, depreciation, and taxes increased by a notable 21% during the fiscal year 2023-24.;